Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A psychedelic renaissance

Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...
Richard (Rick) Mills | December 3, 2019 |

5 of the Biggest Financial Stories From 2019

According to the Chinese Zodiac Calendar, 2019 was the Year of the Pig. Investors and traders, I believe, will likely also remember it as the year of the bull. Every asset type, it seems—from large-caps to small-caps, from foreign to domestic, from gold to oil—fin...
Frank Holmes | December 30, 2019 |

The U.K. Just Said No to EU Socialism. Will U.S. Voters Do the Same in 2020?

Let’s begin with a thought experiment. Imagine you wake up tomorrow from a three and a half-year coma. Everything that’s happened in the meantime—the election of Donald Trump, impeachment, Brexit and more—is a complete mystery to you....
Frank Holmes | December 23, 2019 |

Geospatial Data: A New Tech Play “Experiencing High Growth”

You may not know it, but there’s a whole lot more to satellite imagery than Google Earth. New companies with new technology are now entering the market with practical and essential commercial uses of 3D data and models…including flood & wildfire risk modelli...
Dave Jackson | April 22, 2022 |

Silver and the Yield Curve Inversion

Yield curve inversions have historically been great for silver prices. Currently we are experiencing such a phenomena, and again it is evidence of conditions that are conducive to some impressive silver rallies. Below, is a long-term chart showing the spread between the 10...
Hubert Moolman | September 23, 2019 |

Buzz on the Bullboards: Weathering the Storm?

Sponsored by Now that we’re officially in the second half of 2022, analysts are warning that the rest of the year could prove to be challenging for the stock market. While the first half of the year a...
Jocelyn Aspa | July 7, 2022 |

Expert advises to invest 'wherever value takes you' after rate cut

Allan Small, a senior investment advisor of the Allan Small Financial Group with iA Private Wealth, joins Coreena Robertson in the Expert Exchange to analyze the Bank of Canada’s recent decision to cut interest rates by 50 basis points, the fourth cut th...
Coreena Robertson | November 1, 2024 |

Lithium and copper demand set to grow in 2025

Lithium has already seen a rise in price since the U.S. presidential election and analysts predict a huge demand for copper . Grid Battery Metals (TSXV:CELL) has lithium projects in Nevada and a Copper in British Columbia and the company’s CEO, Tim Fer...
Research | December 6, 2024 |

Karuna Shares Jump 375% Higher on Phase 2 Acute Psychosis Treatment Trial Data

Shares of Karuna Therapeutics, which completed an IPO in July 2019, soared more than 375% higher today after the firm reported that its KarXT met primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia. This morning clinical-stag...
Streetwise Reports | November 19, 2019 |

Weakness Appears To Be Setting For This Weeks Economic Data

As the world reacts to the global economic slowdown because of the COVID-19 virus event and the massive stimulus programs and central bank efforts to support the global economy, investors still expect weakness in the US and foreign markets. We believe this expected weakness ...
Chris Vermeulen | April 1, 2020 |
1 2 3 4 5 6 7 8 9 10